Vaccine, CDC and hepatitis B
Digest more
As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...
Delaying the timing of vaccinating infants against hepatitis B — which ACIP could vote on later this week — would likely lead ...
The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...
A group of advisers to the Centers for Disease Control and Prevention is preparing to vote on whether the agency should scrap ...
The Vaccine Integrity Project’s evidence review of the first dose of the hepatitis B vaccine will offer a transparent, ...
A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B ...
A key advisory panel that oversees nationwide vaccine recommendations may vote to restrict access to hepatitis B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results